New cancer therapies

The specialization of the Biopulse Biotech research group is in biotech. The founding members, Dr. Enrico Pierluigi Spugnini and Prof. Dr. Alfonso Baldi, are internationally considered among the leading experts in Electrochemotherapy and Gene Electrotherapy, as well as among the pioneers of this technique at the clinical level. The imprint given by the members is that of an integrated approach to oncology that, passing through the experimentation and innovative care of the patient in the veterinary field, includes implications on human health in the fields of innovative anti-cancer therapies, DNA vaccines, Drug Delivery methods and methods of loading molecules in vitro.